Skip to main content
An official website of the United States government

Use of CtDNA for Monitoring of Stage III Colorectal Cancer

Sponsor
University of Pittsburgh
Status
Active, not recruiting
NCT ID
NCT02842203
This observational study will evaluate circulating tumor DNA (ctDNA) as a prognostic marker and as a monitor of disease recurrence in stage III colorectal cancer (CRC).
Condition
Stage III Colorectal Cancer
Investigators
Robert Schoen, MD

See list of participating sites